Clonal hematopoiesis: malignant implications, extrahematologic manifestations, and management.

Area of Science:

• Hematology
• Genetics
• Oncology
• Cardiology

Background:

• Aging hematopoietic stem cells can acquire genetic mutations, leading to clonal hematopoiesis.
• While often benign, these mutations can progress to hematologic malignancies like myelodysplastic syndromes and acute myeloid leukemia.
• Clonal hematopoiesis is linked to chronic diseases, including atherosclerotic cardiovascular disease, due to its interactions beyond the blood system.

Purpose of the Study:

• To review the diagnostic methods for clonal hematopoiesis.
• To discuss the clinical implications of clonal hematopoiesis in aging and chronic diseases.
• To explore evolving management strategies for clonal hematopoiesis.

Main Methods:

• Literature review of diagnostic techniques.
• Analysis of clinical studies on clonal hematopoiesis outcomes.
• Synthesis of current and emerging treatment approaches.

Main Results:

• Clonal hematopoiesis diagnosis relies on genetic sequencing of hematopoietic stem cells.
• It is a significant risk factor for hematologic malignancies and chronic inflammatory diseases.
• Management strategies are still evolving, lacking formal consensus.

Conclusions:

• Clonal hematopoiesis is a critical factor in aging, influencing both cancer and chronic disease development.
• Understanding its diagnosis and implications is crucial for patient care.
• Further research is needed to establish clear management guidelines.